Tomorrow's Science For Today's Clinician
This is the first time that Roche has combined two monoclonal antibodies that can be administered by a single SC injection, reducing chair time for patients by 90 percent.
While the specific causes of early onset colorectal cancer remain elusive, data suggest that diets with high intake of red and processed meat, as well as refined grains and processed sugar can alter gut microbial composition, resulting in chronic inflammation, increased rates of obesity and a higher risk of colorectal cancer.
The latest study by Mayo Clinic researchers suggests CAR-T cells can deliver the oncolytic virus to the tumour. Then the virus can infiltrate tumour cells, replicate to bust the cells open, and stimulate a potent immune response.
GRC 54276 is one of the many novel molecules from Glenmark’s in-house Innovative Medicines Group, headed by Dr. Nikhil Amin, chief scientific officer, specialising in the development of novel molecular entities for critical unmet medical needs.
dPCR has quickly become the standard for nucleic acid quantification in oncology, cell and gene therapy development and other research applications because its absolute quantification enables higher accuracy and precision.
Rakuten Medical is focused on developing and commercializing innovative cancer treatments for multiple indications based on its Illuminox platform. Karkinos is a healthcare technology platform focused on delivering quality healthcare by providing access to cancer detection, diagnosis and treatment options. This strategic collaboration will enable continued innovation in cancer care with the goal of transforming cancer care in India and abroad.
The study report suggested that this bacteria could trigger the spread of cancer to other organs as well
Researchers are hoping to develop blood tests that could help to determine luminal and basal subtypes of cancer effectively
During the study, researchers examined erianin, a natural bibenzyl compound, present in Dendrobium chrysotoxum, an orchid species native to Southeast Asia
More than 40 percent of cancer survivors reported being at least moderately burdened by the loss of physical capacity, while one-third suffered from sleeping issues, sexual problems, joint pain, and anxiety